Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 228,918 |
|
|||||
| News | - | ||||||
| Day High | 5.39 | Low High |
|||||
| Day Low | 5.21 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lyra Therapeutics Inc | LYRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.21 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.24 | 5.21 | 5.39 | 5.21 | 5.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,258 | 228,918 | $ 5.26 | $ 1,204,940 | - | 1.93 - 6.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:03 | 12 | $ 5.21 | USD |
Lyra Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 273.85M | 52.56M | - | 1.56M | -62.68M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lyra Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LYRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.24 | 5.77 | 5.07 | 5.33 | 281,194 | -0.03 | -0.57% |
| 1 Month | 6.20 | 6.79 | 4.94 | 5.82 | 470,045 | -0.99 | -15.97% |
| 3 Months | 4.83 | 6.79 | 4.46 | 5.61 | 373,031 | 0.38 | 7.87% |
| 6 Months | 3.58 | 6.79 | 2.50 | 4.94 | 289,000 | 1.63 | 45.53% |
| 1 Year | 2.02 | 6.79 | 1.93 | 4.44 | 277,267 | 3.19 | 157.92% |
| 3 Years | 11.64 | 11.85 | 1.86 | 5.02 | 145,544 | -6.43 | -55.24% |
| 5 Years | 21.00 | 22.00 | 1.86 | 6.63 | 137,486 | -15.79 | -75.19% |
Lyra Therapeutics Description
| Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. |
